相关实验视频

Updated: May 2, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

通过双光谱脑电图,发现了针对感染相关狂妄症的新型保护剂

Tsuyoshi Nishiguchi^1,2, Kyosuke Yamanishi^1,3, Shivani Patel^1,4

¹Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.

Translational psychiatry

|October 2, 2024

概括

双光谱脑电图 (BSEEG) 有助于诊断妄想. 在一个新的小鼠模型中,P7C3-A20和米诺环素保护了与感染相关的痴呆症,与哈洛佩里多尔不同.

科学领域:

神经科学是一个神经科学.
关键护理医学关键护理医学
药理学药理学是指药理学的学科.

背景情况:

妄想是一种严重的疾病,与患者的不良结果有关,但缺乏有效的治疗方法.
诊断痴呆症和验证临床前模型仍然是一个重大挑战.
双光谱脑电图 (BSEEG) 显示出诊断妄和预测结果的前景.

研究的目的:

通过使用BSEEG来描述一种新的脂聚糖 (LPS) 诱导的感染相关妄想的小鼠模型.
在临床前狂妄症模型中验证BSEEG的实用性.
为了评估皮醇,P7C3-A20和米诺环素对LPS诱导的痴呆症的保护功效.

主要方法:

开发和验证LPS诱导的妄小鼠模型.
应用双光谱脑电图 (BSEEG) 来评估类似妄的BSEEG异常.
在暴露于LPS的小鼠中给予哈洛佩里多尔,P7C3-A20或米诺环素.
在年轻小鼠和老年小鼠之间比较BSEEG异常.

主要成果:

年龄较大的小鼠对LPS诱导的BSEEG异常表现出更大的敏感性,反映了人类的脆弱性.
服用P7C3-A20和米诺环素预防了LPS诱导的BSEEG异常在年轻和老年小鼠中.
利治疗没有预防LPS诱导的BSEEG异常.

结论:

BSEEG可以描述和验证一种新的与感染相关的痴呆症的小鼠模型.
P7C3-A20和米诺环素显示出对狂妄症的保护潜力.
该模型提供了一个平台,用于识别和测试治疗剂,以预防妄想.

更多相关视频

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers

Published on: January 13, 2018

A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury

A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury

Published on: March 26, 2019

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...